FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1196.96",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Elimu Informatics Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2019-05-11"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.96",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1196.96"
    }
  ],
  "version": "20190511",
  "name": "CPICRxNORMAtazanavirSCDG",
  "title": "CPIC RxNORM atazanavir SCDG",
  "status": "active",
  "experimental": false,
  "date": "2019-05-11T01:00:10-04:00",
  "publisher": "Elimu Informatics Steward",
  "description": "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are seen with systemically administered medications.\nElimu OID: 2019.05.14.10.51",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having atazanavir as an ingredient.),(Exclusion Criteria: None)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1154364",
            "display": "Atazanavir Oral Product"
          },
          {
            "code": "1154365",
            "display": "Atazanavir Pill"
          },
          {
            "code": "1598983",
            "display": "Atazanavir Oral Powder Product"
          },
          {
            "code": "1601650",
            "display": "Atazanavir / cobicistat Oral Product"
          },
          {
            "code": "1601651",
            "display": "Atazanavir / cobicistat Pill"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:72f0ba7b-0cad-4bf2-8b91-bec37aed7c06",
    "timestamp": "2025-05-23T19:14:09-04:00",
    "total": 5,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154364",
        "display": "atazanavir Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1154365",
        "display": "atazanavir Pill"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1598983",
        "display": "atazanavir Oral Powder Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1601650",
        "display": "atazanavir / cobicistat Oral Product"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1601651",
        "display": "atazanavir / cobicistat Pill"
      }
    ]
  }
}